2017;28:542. 367. Hanson CS, Gutman T, Craig JC, et al. Identifying important outcomes for young people with CKD and their caregivers: a nominal group technique study. Am J Kidney Dis. 2019;74:82 94. 368. Halbach S. Practical application of ABPM in the pediatric nephrology clinic. Pediatr Nephrol. 2020;35:2067 2076. 369. Flynn JT, Carroll MK, Ng DK, et al. Achieved clinic blood pressure level and chronic kidney disease progression in children: a report from the Chronic Kidney Disease in Children Cohort [e-pub ahead of print]. Pediatr Nephrol. https://doi.org/10.1007/s00467-020-04833-8. Accessed January 15, 2021. 370. Kogon AJ, Pierce CB, Cox C, et al. Nephrotic-range proteinuria is strongly associated with poor blood pressure control in pediatric chronic kidney disease. Kidney Int. 2014;85:938 944. 371. Flynn JT, Mitsnefes M, Pierce C, et al. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension. 2008;52:631 637. 372. Hari P, Sahu J, Sinha A, et al. Effect of enalapril on glomerular ltration rate and proteinuria in children with chronic kidney disease: a randomized controlled trial. Indian Pediatr. 2013;50:923 928. 373. Seeman T, Gilik J, Vondrak K, et al. Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy. Am J Hypertens. 2007;20:990 996. 374. Cheung AK, Chang TI, Cushman WC, et al. Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;95: 1027 1036. 375. Institute of Medicine (IOM) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. In: Graham R, Mancher M, Miller Wolman D, et al., eds. Clinical Practice Guidelines We Can Trust. Washington DC: National Academies Press; 2011. 376. Schunemann HJ, Fretheim A, Oxman AD. Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations. 